Detalles de la búsqueda
1.
Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants.
Antimicrob Agents Chemother
; 66(4): e0225121, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315687
2.
Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid-dependent, human immunodeficiency virus seronegative participants.
Br J Clin Pharmacol
; 85(8): 1771-1780, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30980734
3.
Antiviral Activity, Safety, and Exposure-Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002).
Clin Infect Dis
; 65(3): 442-452, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28369211
4.
Population Pharmacokinetics Analysis To Inform Efavirenz Dosing Recommendations in Pediatric HIV Patients Aged 3 Months to 3 Years.
Antimicrob Agents Chemother
; 60(6): 3676-86, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27067333
5.
Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.
J Antimicrob Chemother
; 67(2): 465-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22121190
6.
Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
Pediatr Infect Dis J
; 37(6): e157-e165, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29206748
7.
Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study.
J Acquir Immune Defic Syndr
; 71(5): 538-43, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26605505
8.
A randomized trial in healthy subjects to assess the bioequivalence of an atazanavir/cobicistat fixed-dose combination tablet versus administration as separate agents.
Antivir Ther
; 20(5): 493-500, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25361436
9.
Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922.
Pediatr Infect Dis J
; 34(12): 1355-60, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26379163
10.
Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
Antivir Ther
; 19(5): 511-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24343001
11.
The pharmacokinetics of daclatasvir and asunaprevir administered in combination in studies in healthy subjects and patients infected with hepatitis C virus.
Clin Drug Investig
; 34(9): 661-71, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117173
12.
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
Antivir Ther
; 18(7): 931-40, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23963204
13.
The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
Antivir Ther
; 16(2): 149-56, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21447863
Resultados
1 -
13
de 13
1
Próxima >
>>